• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIO-RAD LABORATORIES, INC. LIQUID ASSAYED MULTIQUAL, LEVEL 3; MUITI-ANALYTE CONTROLS, ALL KINDS (ASSAYED)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIO-RAD LABORATORIES, INC. LIQUID ASSAYED MULTIQUAL, LEVEL 3; MUITI-ANALYTE CONTROLS, ALL KINDS (ASSAYED) Back to Search Results
Model Number 696
Medical Device Problem Code Human-Device Interface Problem (2949)
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 03/04/2020
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The instruction for use provided by bio-rad for testing liquid assayed multiqual control indicated the product contains human source materials and should be considered potentially infectious and handled with the same precautions used with patient specimens in accordance with good laboratory practice.Each human donor unit used to manufacture this product was tested as required by fda accepted methods.Tests results were non-reactive for (b)(6) surface antigen ((b)(6)), antibody to (b)(6), and antibody to (b)(6).This product may also contain other human source materials for which there are no approved tests.In accordance with good laboratory practice, all human source material should be considered potentially infectious and handled with the same precautions used with patient specimens.
 
Event or Problem Description
On march 04, 2020, a laboratory information manager from va medical center- (b)(6) called bio-rad qsd technical support to report a potential adverse event that occurred with a technician at their facility.In the facility chemistry lab, the employee removed qc rack from instrument and emptied a rack of qc vials into sink.While dumping, the mixture of qc splashed into the technician's eyes.The technician was not wearing safety glasses, which is a laboratory requirement for ppe in this facility.The following qc products were on the qc rack and plashed in the technician's eyes: liquichek immunoassay plus control: trilevel: lot 41000; liquichek cardiac markers plus control lt: level 2: lot 23692, level 3: lot 23693, level 1b: lot 23695; liquid assayed multiqual: level 1: lot 45791, level 3: lot 45793.The employee washed eyes immediately in the emergency eye wash station.The incident was reported to facilities health and the employee was sent to the employee health center for evaluation.No details of the visit to employee health center was provided.It was reported that no additional medical attention was required.The employee and facility was provided with package insert, sds and certificate of analysis for all 8 products that were splashed in the technician's eyes.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LIQUID ASSAYED MULTIQUAL, LEVEL 3
Common Device Name
MUITI-ANALYTE CONTROLS, ALL KINDS (ASSAYED)
Manufacturer (Section D)
BIO-RAD LABORATORIES, INC.
9500 jeronimo road
irvine, ca
MDR Report Key9806098
Report Number2016706-2020-00007
Device Sequence Number778814
Product Code JJY
UDI-Device Identifier00847661001294
UDI-Public00847661001294
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
K043208
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source health professional,user faci
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date (Section B) 03/09/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Other
Device Expiration Date03/31/2020
Device Model Number696
Device Catalogue Number696
Device Lot Number45793
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 03/05/2020
Initial Report FDA Received Date03/09/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
-
-